Detection of the pharmaceutical agent glaucine as a recreational drug

European Journal of Clinical Pharmacology

Volumn 64, Issue 5, 2008, Pages 553-554

  Dargan, Paul I ^a   Button, Jenny ^b   Hawkins, Leonard ^a   Archer, John R H ^b   Ovaska, Hanna ^a   Lidder, Satnam ^a   Ramsey, John ^b   Holt, David W ^b   Wood, David M ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Drug legislation; Glaucine; Recreational drugs; Toxicological screening

Indexed keywords

1 BENZYLPIPERAZINE DERIVATIVE; CYCLIZINE; GLAUCINE; GLAUVENT; PROCHLORPERAZINE; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

ADULT; AGITATION; CASE REPORT; DRUG ABUSE; DRUG DETERMINATION; DRUG INDICATION; DRUG INTOXICATION; DRUG LEGISLATION; EMERGENCY TREATMENT; FEMALE; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPNEA; TOXICITY TESTING; VOMITING;

ADULT; ANTITUSSIVE AGENTS; APORPHINES; FEMALE; HUMANS; STREET DRUGS;

EID: 41049117217     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0451-9     Document Type: Letter

References (3)

1. Rovinskia VI (1989) A case of hallucinogen-like action of glaucine. Klin Med (Mosk) 67:107-108
2. Rovinskia VI (2006) Acute glaucine syndrome in the physician's practice: the clinical picture and potential danger. Klin Med (Mosk) 84:68-70
3. Asencio M, Hurtado-Guzmán C, López JJ et al (2005) Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity. Bioorg Med Chem 13:3699-3704